Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Equity Ratio (2020 - 2026)

RxSight filings provide 6 years of Equity Ratio readings, the most recent being 0.88 for Q4 2025.

  • On a quarterly basis, Equity Ratio changed 0.15% to 0.88 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.88, a 0.15% change, with the full-year FY2025 number at 0.88, changed 0.15% from a year prior.
  • Equity Ratio hit 0.88 in Q4 2025 for RxSight, down from 0.89 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.9 in Q2 2024 to a low of 3.3 in Q2 2021.
  • Median Equity Ratio over the past 5 years was 0.88 (2023), compared with a mean of 0.59.
  • The widest YoY moves for Equity Ratio: up 119.97% in 2022, down 16.79% in 2022.
  • RxSight's Equity Ratio stood at 0.72 in 2021, then dropped by 16.54% to 0.6 in 2022, then surged by 46.73% to 0.88 in 2023, then rose by 0.5% to 0.88 in 2024, then increased by 0.15% to 0.88 in 2025.
  • The last three reported values for Equity Ratio were 0.88 (Q4 2025), 0.89 (Q3 2025), and 0.9 (Q2 2025) per Business Quant data.